Aditxt (ADTX) Receivables - Net (2020 - 2026)

Aditxt (ADTX) recorded quarterly Receivables - Net of $11974.0 in Q1 2026, down 89.82% quarter-over-quarter from $117651.0 in Q3 2025, and down 90.02% on a YoY basis from $120026.0 in Q1 2025.

Aditxt (ADTX) Receivables - Net (2020 - 2026) Analysis & Trends

Aditxt's Receivables - Net history runs 7 years deep, the most recent figure standing at $11974.0 for Q1 2026.

  • In Q1 2026, Receivables - Net fell 90.02% year-over-year to $11974.0; the TTM figure through Mar 2026 stood at $11974.0 (down 90.02% YoY), while the FY2024 annual figure was $121582.0, down 70.22% from the prior year.
  • Receivables - Net was $11974.0 for Q1 2026 at Aditxt, down from $117651.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $662810.0 in Q3 2022 to a low of $11974.0 in Q1 2026.
  • Historically, Receivables - Net has averaged $299278.1 across 5 years, with a median of $340364.0 in 2023.
  • The sharpest annual moves came in 2022 and 2026: Receivables - Net soared 487.64% in 2022, then slumped 90.02% in 2026.
  • A 5-year view of Receivables - Net shows it stood at $527961.0 in 2022, then fell by 22.66% to $408326.0 in 2023, then plunged by 70.22% to $121582.0 in 2024, then slipped by 3.23% to $117651.0 in 2025, then plunged by 89.82% to $11974.0 in 2026.
  • The last three Receivables - Net figures came in at $11974.0 (Q1 2026), $117651.0 (Q3 2025), and $117651.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Aditxt 2,485.68 -2.16 Mn 2,868.00

Historic Data

Download Data
DateValue
Mar 31, 2026 11,974.00
Mar 31, 2026 11,974.00
Sep 30, 2025 117,651.00
Sep 30, 2025 117,651.00
Jun 30, 2025 117,651.00
Jun 30, 2025 117,651.00
Mar 31, 2025 120,026.00
Mar 31, 2025 120,026.00
Dec 31, 2024 121,582.00
Dec 31, 2024 121,582.00
Sep 30, 2024 351,707.00
Sep 30, 2024 351,707.00
Jun 30, 2024 191,452.00
Jun 30, 2024 191,452.00
Mar 31, 2024 427,044.00
Mar 31, 2024 427,044.00
Dec 31, 2023 408,326.00
Dec 31, 2023 408,326.00
Sep 30, 2023 362,708.00
Sep 30, 2023 362,708.00